Bio-Path Holdings, Inc. (BPTH)
OTCMKTS · Delayed Price · Currency is USD
0.0620
+0.0020 (3.33%)
At close: Feb 26, 2026
Bio-Path Holdings Market Cap
Bio-Path Holdings has a market cap or net worth of $579.21 thousand as of February 26, 2026. Its market cap has decreased by -82.78% in one year.
Market Cap
579.21K
Enterprise Value
1.06M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.06
Market Cap Chart
Since February 15, 2008, Bio-Path Holdings's market cap has decreased from 31.22M to 579.21K, a decrease of -98.14%. That is a compound annual growth rate of -19.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 579.21K | 4.45% |
| Dec 31, 2025 | 554.53K | -88.90% |
| Dec 31, 2024 | 5.00M | -12.65% |
| Dec 29, 2023 | 5.72M | -52.42% |
| Dec 30, 2022 | 12.02M | -55.47% |
| Dec 31, 2021 | 26.99M | 69.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protagenic Therapeutics | 867.55K |
| EV Biologics | 840.53K |
| Lipella Pharmaceuticals | 785.54K |
| SQZ Biotechnologies Company | 707.79K |
| Aibotics | 691.83K |
| Scorpius Holdings | 611.43K |
| Helix BioMedix | 606.71K |
| Altamira Therapeutics | 605.84K |